JP2019512511A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512511A5
JP2019512511A5 JP2018549202A JP2018549202A JP2019512511A5 JP 2019512511 A5 JP2019512511 A5 JP 2019512511A5 JP 2018549202 A JP2018549202 A JP 2018549202A JP 2018549202 A JP2018549202 A JP 2018549202A JP 2019512511 A5 JP2019512511 A5 JP 2019512511A5
Authority
JP
Japan
Prior art keywords
alkyl
conjugate
pharmaceutically acceptable
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549202A
Other languages
English (en)
Japanese (ja)
Other versions
JP7027325B2 (ja
JP2019512511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/022785 external-priority patent/WO2017161170A1/en
Publication of JP2019512511A publication Critical patent/JP2019512511A/ja
Publication of JP2019512511A5 publication Critical patent/JP2019512511A5/ja
Application granted granted Critical
Publication of JP7027325B2 publication Critical patent/JP7027325B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549202A 2016-03-16 2017-03-16 炭酸無水酵素ixを標的とする薬剤および方法 Expired - Fee Related JP7027325B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662309264P 2016-03-16 2016-03-16
US201662309268P 2016-03-16 2016-03-16
US62/309,268 2016-03-16
US62/309,264 2016-03-16
PCT/US2017/022785 WO2017161170A1 (en) 2016-03-16 2017-03-16 Carbonic anhydrase ix targeting agents and methods

Publications (3)

Publication Number Publication Date
JP2019512511A JP2019512511A (ja) 2019-05-16
JP2019512511A5 true JP2019512511A5 (enExample) 2020-04-23
JP7027325B2 JP7027325B2 (ja) 2022-03-01

Family

ID=59852046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549202A Expired - Fee Related JP7027325B2 (ja) 2016-03-16 2017-03-16 炭酸無水酵素ixを標的とする薬剤および方法

Country Status (6)

Country Link
US (2) US11925696B2 (enExample)
EP (1) EP3429575A4 (enExample)
JP (1) JP7027325B2 (enExample)
AU (1) AU2017234676A1 (enExample)
CA (1) CA3017214A1 (enExample)
WO (1) WO2017161170A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017161170A1 (en) 2016-03-16 2017-09-21 Purdue Research Foundation Carbonic anhydrase ix targeting agents and methods
EP3429637A4 (en) * 2016-03-16 2020-03-11 Endocyte, Inc. CONJUGATES OF CARBONIC ANHYDRASE IX INHIBITORS AND USES THEREOF
US20210322582A1 (en) * 2018-08-30 2021-10-21 Nihon Medi-Physics Co., Ltd. Radioactive imidazothiadiazole derivative compound
AU2024266164A1 (en) * 2023-05-02 2025-10-30 Rayzebio, Inc. Radiopharmaceutical compositions targeting carbonic anhydrase ix and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2260875T3 (da) * 2002-05-06 2014-06-30 Endocyte Inc Folatreceptor-targetede billeddannelsesmidler
AU2004211584B2 (en) * 2003-01-31 2009-11-12 Promega Corporation Covalent tethering of functional groups to proteins
US20060211074A1 (en) * 2005-01-12 2006-09-21 Boyce James P Kinase-directed, activity-based probes
CN103893778A (zh) 2005-08-19 2014-07-02 恩多塞特公司 多药物配体缀合物
US20090043099A1 (en) 2006-03-17 2009-02-12 The Burnham Institute Methods and compositions for derepression of IAP-inhibited caspase
WO2008101231A2 (en) 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
WO2009002993A1 (en) 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
PT2187965T (pt) * 2007-08-17 2020-01-17 Purdue Research Foundation Conjugados ligando-ligante de ligação a psma e métodos para utilização
EP2240171B1 (en) * 2008-01-09 2014-08-13 Molecular Insight Pharmaceuticals, Inc. Inhibitors of carbonic anhydrase IX
EP2391714B2 (en) 2009-01-30 2019-07-24 Whitehead Institute for Biomedical Research Methods for ligation and uses thereof
CN101596433B (zh) 2009-07-15 2011-07-06 中国科学院工程热物理研究所 U形返料器的冷却式隔板
FR2951449B1 (fr) 2009-10-15 2011-11-25 Commissariat Energie Atomique Procede de fonctionnalisation de molecules biologiques
WO2011090710A2 (en) * 2009-12-28 2011-07-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Composite probes and use thereof in super resolution methods
WO2011098610A1 (en) * 2010-02-12 2011-08-18 Universita Degli Studi Di Firenze Carbonic anhydrase inhibitors
JP5544239B2 (ja) * 2010-07-29 2014-07-09 富士フイルム株式会社 重合性組成物
EP2707102B1 (en) * 2011-05-09 2019-11-13 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same
HUE068833T2 (hu) 2011-08-17 2025-01-28 Merck & Cie Kmg Albumint megkötõ egységek folát konjugátjai
US20140249315A1 (en) 2013-03-01 2014-09-04 Endocyte, Inc. Processes for preparing tubulysins
US10183970B2 (en) 2014-01-28 2019-01-22 Tube Pharmaceuticals Gmbh Cytotoxic tubulysin compounds for conjugation
US9771380B2 (en) 2014-06-09 2017-09-26 University Of Oregon Gold nanoparticles and methods of making and using gold nanoparticles
EP3429637A4 (en) * 2016-03-16 2020-03-11 Endocyte, Inc. CONJUGATES OF CARBONIC ANHYDRASE IX INHIBITORS AND USES THEREOF
WO2017161170A1 (en) 2016-03-16 2017-09-21 Purdue Research Foundation Carbonic anhydrase ix targeting agents and methods
CA3019835A1 (en) * 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy

Similar Documents

Publication Publication Date Title
JP2019512511A5 (enExample)
JP2016153410A5 (enExample)
JP2019537599A5 (enExample)
JP2016505586A5 (enExample)
JP2006515838A5 (enExample)
JP2019519491A5 (enExample)
JP2014531434A5 (enExample)
JP2004516314A5 (enExample)
JP2017511360A5 (enExample)
JP2007504235A5 (enExample)
JP2019524883A5 (enExample)
JP2017511815A5 (enExample)
JP2006507265A5 (enExample)
JP2016514192A5 (enExample)
JP2008510691A5 (enExample)
JP2010523599A5 (enExample)
JP2011251990A5 (enExample)
JP2011528654A5 (enExample)
JP2016523270A5 (enExample)
JP2014511891A5 (enExample)
JP2013523652A5 (enExample)
JP2012533546A5 (enExample)
JP2012504608A5 (enExample)
JP2018525405A5 (enExample)
JP2012092103A5 (enExample)